Recent News
Ventria Continues Partnership With The Chase Group to Find Agronomy Operations Leader
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →
Building the Next Generation of RNA Medicines – With Exceptional Talent
Arcturus Therapeutics, an RNA medicines company engaged in the development of therapeutics for rare diseases and vaccines – including one in clinical trials for COVID-19 – is growing quickly and adding key executives in clinical development and drug safety. To find this elite group of clinicians, the company relies on The Chase Group and its network of carefully curated candidates, expert screening skills, and comprehensive project management that leaves nothing to chance. Continue Reading →Ventria Bioscience Cuts to The Chase!
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →
Ferrer Partners With The Chase Group to Identify US Business Development Leader
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,… Continue Reading →Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →